Association between the Met326Ile polymorphism of the p85α regulatory subunit of phosphatidylinositol 3-kinase and prostate cancer risk: A prospective study

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 2, 2003, Pages 172-173

  Paradis, Aimée E ^a   Kantoff, Philip W ^a   Giovannucci, Edward ^b,c   Stampfer, Meir J ^b,c   Ma, Jing ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL TRIAL; CODON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; DOUBLE BLIND PROCEDURE; GENE CONTROL; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGED; ALLELES; CASE-CONTROL STUDIES; CODON; DOUBLE-BLIND METHOD; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; STATISTICS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 0037318537     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lin, J., Adam, R., Santiestevan, E., and Freeman, M. The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells, Cancer Res., 59: 2891-2897, 1999.
2. Wu, X., Senechal, K., Neshat, M., Whang, Y., and Sawyers, C. The PTEN/ MMAC? tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA, 95: 15587-15591, 1998.
3. Chan, J., Stampfer, M., Giovannucci, E., Gann, P., Ma, J., Wilkinson, P., Hennekens, C., and Pollak, M. Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science (Wash. DC), 279: 563-566, 1998.
4. Stattin. P., Bylund, A., Rinaldi, S., Biessy, C., Dechaud, H., Stenman, U. H., Egevad, L., Riboli, E., Hallmans, G., and Kaaks, R. Plasma insulin-like growth factor-I, insulin-like growth factor binding proteins, and prostate cancer risk; a prospective study. J. Natl. Cancer Inst. (Bethesda), 92: 1910-1917, 2000.
5. Fruman, D., Meyers, R., and Cantley, L. Phosphoinositide kinases. Annu. Rev. Biochem., 67: 481-507, 1998.
6. Baier, L., Wiedrich, C., Hanson, R., and Bogardus, C. Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85α): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes, 47: 973-975, 1998.
7. Hansen, T., Andersen, C., Echwald, S., Urhammer, S., Clausen, J., Vestergaard, H., Owens, D., Hansen, L., and Pedersen, O. Identification of a common amino acid polymorphism in the p85a regulatory subunit of phophatidylinositol 3-kinase. Diabetes, 46: 494-501, 1997.
8. Baynes, K., Beeton, C., Panayotou, G., Stein, R., Soos, M., Hansen, T., Simpson, H., O'Rahilly, S., Shepherd, P., and Whitehead, J. Natural variants of human p85α phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity. Diabetologia, 43: 321-331, 2000.
9. Hansen, L., Zethelius, B., Berglund, L., Reneland, R., Hansen, T., Berne, C., Lithell, H., Hemmings, B. A., and Pedersen, O. In vitro and in vivo studies of a naturally occurring variant of the human p85a regulatory subunit of the phosphoinositide 3-kinase: inhibition of protein kinase B and relationships with type 2 diabetes, insulin secretion, glucose disappearance constant, and insulin sensitivity. Diabetes, 50: 690-693, 2001.
10. Giovannucci, E., Stampfer, M., Krithivas, K., Brown, M., Brufsky, A., Talcott, J., Hennekens, C., and Kantoff, P, The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad. Sci, USA, 94: 3320-3323, 1997.